Why the study?
Many hypertensive individuals are resistant to standard treatments, prompting the examination of oxidative stress mechanisms and antioxidant medications to improve hypertension management.
Do antioxidant medications improve the management of hypertension and its associated organ damage in hypertensive individuals?
Do antioxidant medications improve the management of hypertension and its associated organ damage in hypertensive individuals?
This review highlights the potential role of antioxidant medications as an adjunct to standard antihypertensive therapy in managing hypertension and preventing organ damage.
Antioxidants may adjunctively aid hypertension management; leaves open clinical efficacy for organ protection without randomized trials.
As a major cause of morbidity and mortality globally, hypertension remains a serious threat to global public health. Despite the availability of many antihypertensive medications, several hypertensive individuals are resistant to standard treatments, and are unable to control their blood pressure. Regulation of the renin-angiotensin-aldosterone system (RAAS) controlling blood pressure, activation of the immune system triggering inflammation and production of reactive oxygen species, leading to oxidative stress and redox-sensitive signaling, have been implicated in the pathogenesis of hypertension. Thus, besides standard antihypertensive medications, which lower arterial pressure, antioxidant medications were tested to improve antihypertensive treatment. We review and discuss the role of oxidative stress in the pathophysiology of hypertension and the potential use of antioxidants in the management of hypertension and its associated organ damage.
No takes yet. Share an insight, caveat, or question.
Amponsah-Offeh et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: